Optimization of conditions for expression of recombinant interferon-γ in E.coli

被引:9
|
作者
Kumar, Meetul [1 ]
Singh, Mrinalini [1 ]
Singh, Shashi Bala [1 ]
机构
[1] Def Res & Dev Org, Def Inst Physiol & Allied Sci, New Delhi 110054, India
关键词
Interferon-gamma; Immunomodulation; Protein purification; Cell viability; NITRIC-OXIDE; MONONUCLEAR PHAGOCYTES; CHROMATOGRAPHY; MACROPHAGES; RECEPTOR; ANTIGEN; SEARCH; MICE;
D O I
10.1007/s11033-014-3537-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon gamma (IFN-gamma) is an important immunoregulatory cytokine that has a central role against viral and bacterial infections. In this study, the cDNA encoding 141 amino acids of mature IFN-gamma from mice splenocytes was cloned in a prokaryotic expression vector pQE 30. Optimization of expression conditions resulted in high IFN-gamma protein. Western blot showed that recombinant IFN-gamma was specifically recognized by its counterpart anti-mouse IFN-gamma antibodies. In vitro dose-dependent studies, with A549 and HeLa cell lines, showed that cloned IFN-gamma was safe and had no effect on cell proliferation. The protein prediction and analysis using SOPMA program, revealed that IFN-gamma had 80 alpha-helices, 8 beta-turns jointed by 9 extended strands and 44 random coils. A total of four major clusters were observed with murine IFN-gamma sharing 39 % homology with human IFN-gamma. Pair-wise alignment studies with human revealed 26 % identity and 43.3 % similarity. The recovery of bioactive proteins from inclusion bodies (IBs) is a complex process and various protocols have been developed. We report here a simple, robust and inexpensive purification approach for obtaining recombinant IFN-gamma protein expressed as IBs in E.coli.
引用
收藏
页码:6537 / 6543
页数:7
相关论文
共 50 条
  • [1] Optimization of conditions for expression of recombinant interferon-γ in E.coli
    Meetul Kumar
    Mrinalini Singh
    Shashi Bala Singh
    Molecular Biology Reports, 2014, 41 : 6537 - 6543
  • [2] High expression of synthetic human interferon-γ cDNA in E.coli
    王子轩
    杨迪
    王启松
    李伯良
    吕兆海
    虞建良
    郑宏大
    范佩芳
    唐建伟
    钱民章
    郭海鸿
    姚曼华
    郑仲承
    刘新垣
    Science in China(Series B), 1995, (09) : 1084 - 1093
  • [3] Expression of enterobacter cloacae hydA gene in E.coli and the fermentative hydrogen production of the recombinant E.coli
    Zhao, Jinfang
    Cheng, Jun
    Qi, Feng
    Zhang, Chuanxi
    Taiyangneng Xuebao/Acta Energiae Solaris Sinica, 2009, 30 (06): : 829 - 832
  • [4] Optimization of cultural conditions for enhancing the expression of human interferon-α2a by recombinant yeast
    Chu, J
    Zhang, SL
    Zhuang, YP
    PROCESS BIOCHEMISTRY, 2004, 39 (12) : 2069 - 2073
  • [5] Expression of biologically active recombinant equine interferon-γ in Escherichia coli
    Bai, Yu
    Tong, Tiegang
    Liu, Guangliang
    Chen, Weiye
    Zhang, Weijun
    Wang, Qun
    Yang, Tao
    Bu, Zhigao
    Wu, Donglai
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2010, 33 (04) : 333 - 342
  • [6] Maximizing Production of Human Interferon-γ in HCDC of Recombinant E. coli
    Babaeipour, Valiollah
    Shojaosadati, Seyed Abbas
    Maghsoudi, Nader
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (03): : 563 - 572
  • [7] Recombinant Protein Expression in Escherichia coli (E.coli): What We Need to Know
    Hayat, Seyed Mohammad Gheibi
    Farahani, Najmeh
    Golichenari, Behrouz
    Sahebkar, Amirhossein
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (06) : 718 - 725
  • [8] Expression,Purification and Identification of Recombinant Mouse Interleukin 21 Protein in E.coli
    Weiguo Tang
    Jinling Pharmaceutical Co.
    Cellular & Molecular Immunology, 2006, (04) : 311 - 315
  • [9] Investigation on the Purification and Expression of Cell Ⅰ-Hep Ⅱ Recombinant FN Polypeptide in E.Coli
    张桂梅
    冯作化
    李东
    张慧
    同济医科大学学报(外文版), 1996, (03) : 134 - 138
  • [10] Cloning, expression and purification of Chikungunya virus E2 recombinant protein in E.coli
    Anil Kr Verma
    Anmol Chandele
    Murali-Krishna Kaja
    Arockiasamy Arulandu
    Pratima Ray
    BMC Infectious Diseases, 14 (Suppl 3)